BACKGROUND: A significant percentage of breast cancer survivors are at risk for lymphedema for which lifelong self-care is required. Previous studies suggest that less than 50% of breast cancer survivors with lymphedema (BCS-LE) perform prescribed self-care tasks and that even wearing a compression sleeve, the most commonly reported self-care activity, is done irregularly. Reasons for poor self-care adherence include perceived lack of results from self-care (no available arm volume data) and perceived inability to manage the condition. METHODS AND RESULTS: A two-part pilot study was conducted to: 1) develop and determine the feasibility of a self-measurement protocol using a single frequency bioelectrical impedance device; and 2) examine daily variation in extracellular volume in healthy and lymphedematous limbs. Healthy and BCS-LE volunteers were recruited to refine and test a self-measurement protocol. Volunteers were trained in the use of the device and measured for 5 consecutive days in a laboratory setting. They were then given the device to use at home for an additional 5 consecutive days of self-measurement. All volunteers completed each scheduled home measurement. Daily variability in both groups was noted. CONCLUSIONS: Home self-measurement using bioelectrical impedance is feasible, acceptable, and captures change. This has implications for both self-care support and for the possibility of incorporating self-measurement using bioelectrical impedance in future clinical trials examining effectiveness of lymphedema treatment.
BACKGROUND: A significant percentage of breast cancer survivors are at risk for lymphedema for which lifelong self-care is required. Previous studies suggest that less than 50% of breast cancer survivors with lymphedema (BCS-LE) perform prescribed self-care tasks and that even wearing a compression sleeve, the most commonly reported self-care activity, is done irregularly. Reasons for poor self-care adherence include perceived lack of results from self-care (no available arm volume data) and perceived inability to manage the condition. METHODS AND RESULTS: A two-part pilot study was conducted to: 1) develop and determine the feasibility of a self-measurement protocol using a single frequency bioelectrical impedance device; and 2) examine daily variation in extracellular volume in healthy and lymphedematous limbs. Healthy and BCS-LE volunteers were recruited to refine and test a self-measurement protocol. Volunteers were trained in the use of the device and measured for 5 consecutive days in a laboratory setting. They were then given the device to use at home for an additional 5 consecutive days of self-measurement. All volunteers completed each scheduled home measurement. Daily variability in both groups was noted. CONCLUSIONS: Home self-measurement using bioelectrical impedance is feasible, acceptable, and captures change. This has implications for both self-care support and for the possibility of incorporating self-measurement using bioelectrical impedance in future clinical trials examining effectiveness of lymphedema treatment.
Authors: Paula M C Donahue; Rachelle Crescenzi; Allison O Scott; Vaughn Braxton; Aditi Desai; Seth A Smith; John Jordi; Ingrid M Meszoely; Ana M Grau; Rondi M Kauffmann; Raeshell S Sweeting; Kandace Spotanski; Sheila H Ridner; Manus J Donahue Journal: Lymphat Res Biol Date: 2017-03 Impact factor: 2.589
Authors: Sheila H Ridner; Ya-Chen Tina Shih; Jennifer K Doersam; Bethany Andrews Rhoten; Benjamin S Schultze; Mary S Dietrich Journal: Lymphat Res Biol Date: 2014-12 Impact factor: 2.589
Authors: Paula M C Donahue; Rachelle Crescenzi; Chelsea Lee; Maria Garza; Niral J Patel; Kalen J Petersen; Manus J Donahue Journal: Breast Cancer Res Treat Date: 2020-06-29 Impact factor: 4.872
Authors: Danielle M Peterson; Eliza W Beal; Brenda F Reader; Curtis Dumond; Sylvester M Black; Bryan A Whitson Journal: ASAIO J Date: 2022-01-20 Impact factor: 3.826
Authors: Louise A Koelmeyer; Emma Moloney; John Boyages; Kerry A Sherman; Catherine M Dean Journal: Breast Cancer Res Treat Date: 2020-10-01 Impact factor: 4.872